{"transactions":[{"id":1753885,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":108722,"kind":"person","name":"Malenfant Gavin T.","position":1,"cik":"0001927060","reported_name":"Malenfant Gavin T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option (right to buy)","published_at":"2023-10-30T19:51:12.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months."}],"balance_after":12500,"derivative":{"exercise_price":1.87,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-23-056504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927060/000095017023056504/ownership.xml","form_type":"4"}},{"id":1796555,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":108722,"kind":"person","name":"Malenfant Gavin T.","position":1,"cik":"0001927060","reported_name":"Malenfant Gavin T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants to purchase Common Shares","published_at":"2023-08-25T16:15:24.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2660,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 2,660 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 2,660 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":2660,"derivative":{"exercise_price":1.75,"exercise_date":"2024-02-21","expiration_date":"2029-02-21","underlying":"Common Shares","underlying_shares":2660},"source":{"system":"sec-edgar","filing":"0000899243-23-018463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1927060/000089924323018463/doc4.xml","form_type":"4"}},{"id":1796554,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":108722,"kind":"person","name":"Malenfant Gavin T.","position":1,"cik":"0001927060","reported_name":"Malenfant Gavin T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2023-08-25T16:15:24.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2660,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 2,660 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 2,660 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":2660,"source":{"system":"sec-edgar","filing":"0000899243-23-018463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927060/000089924323018463/doc4.xml","form_type":"4"}}]}